GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Global Clinical Research & Pharmacovigilance

Overview… ,[object Object],[object Object],[object Object]

Benefits of developing pharmacovigilance in India

Incredible India… ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

India Today… ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Challenges… ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Challenges… ,[object Object],[object Object],aim : is to protect public health by identifying, evaluating and minimizing safety issues

Analyzing the current & future of PV In India

PHARMACOVIGILANCE IN INDIA 1986 ADR Monitoring System which contained 12 regional centers was proposed 1997 - India joined the World Health Organization (WHO) Adverse Drug Reaction Monitoring Program based in Uppsala, Sweden. -National Pharmacovigilance Centre (AIIMS, New Delhi) -WHO centre (KEM Hospital, Mumbai) -WHO centre (JLN Hospital, Aligarh Muslim University Unsuccessful attempt 01 Jan 2005 - the WHO-sponsored and World Bank-funded National Pharmacovigilance Program for India was made operational.

NATIONAL PHARMACOVIGILANCE PROGRAM ,[object Object],[object Object],[object Object],Hence from 1986 – Till Date, things have definitely changed for the better but at a very slow pace. the questions that arise are whether the strategy should be changed and if so, how? ?

National Pharmacovigilance Programme ,[object Object],[object Object],[object Object]

Asian J of Pharmaceutical & Clinical Research 2009;2(2): 10 - 14 ADVERSE DRUG REACTIONS REPORTING: ATTITUDES AND PERCEPTIONS OF MEDICAL PRACTITIONERS

Asian J of Pharmaceutical & Clinical Research 2009;2(2): 10 - 14

IJP 2008;40(1): S31- 34 From BJ Medical College, A’bad

Ground reality in ADR detection ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Courtesy : Dr YK Amdekar (IDMA PV Conf, 2009 Mumbai)

Where does fault lie? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Courtesy : Dr YK Amdekar (IDMA PV Conf, 2009 Mumbai)

Where does fault lie? ,[object Object],[object Object],Courtesy : Dr YK Amdekar (IDMA PV Conf, 2009 Mumbai)

Solutions to minimise ADRs ,[object Object],[object Object],[object Object],[object Object],Courtesy : Dr YK Amdekar (IDMA PV Conf, 2009 Mumbai)

Robust PV System in India ,[object Object],[object Object],[object Object],[object Object],Cont’d…

[object Object],[object Object],[object Object],[object Object]

Soliciting ADR reporting from private practitioners ,[object Object],[object Object],[object Object],[object Object],[object Object],Courtesy : Dr YK Amdekar (IDMA PV Conf, 2009 Mumbai)

FUTURE STRATEGIES AND PROPOSALS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],FUTURE STRATEGIES AND PROPOSALS

Use of Media & Organizations ,[object Object],[object Object],[object Object],[object Object]

GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Global Clinical Research & Pharmacovigilance

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (20)

Similar to GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Global Clinical Research & Pharmacovigilance

Similar to GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Global Clinical Research & Pharmacovigilance (20)

More from Until ROI

More from Until ROI (12)

Recently uploaded

Recently uploaded (20)

GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Global Clinical Research & Pharmacovigilance